News & Events
ATP's four portfolio companies have delivered exceptional results in 2009 and following are some recent highlights:
 |
Celgene to Acquire Gloucester Pharmaceuticals December 7 2009
"Celgene Corporation (NASDAQ:CELG) and Gloucester Pharmaceuticals Inc., a privately held pharmaceutical company, announced a definitive merger agreement under which Celgene Corporation will acquire Gloucester Pharmaceuticals...."
|
|
 |
Tokai eyes novel weapon to battle prostate cancer
November 27 2009
"Tokai Pharmaceuticals has begun a clinical trial for a new prostate cancer drug candidate after quietly raising cash over the...."
|
|
 |
Aileron Therapeutics Collaborators Publish In Vivo Research in Nature Showing Stapled Peptides Achieve the First Direct Inhibition of the Notch1 Transcription Factor Oncogene
November 11 2009
"Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides...."
Link to Abstract
|
|
 |
Tokai Pharmaceuticals Initiates ARMOR Clinical Development Program for TOK-001; First Ever Multi-Target Investigational Drug for Prostate Cancer
November 10 2009
"Tokai Pharmaceuticals, Inc., today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the...."
|
|
 |
FDA Approves Gloucester Pharmaceuticals' ISTODAX® for Patients with Cutaneous T-cell Lymphoma November 5 2009
"Gloucester Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) approved ISTODAX® (romidepsin)...."
|
|
 |
FDA Advisory Committee Recommends Gloucester Pharmaceuticals’ Romidepsin for Approval for Cutaneous T-cell Lymphoma September 2 2009
"Gloucester Pharmaceuticals announced today that the Oncologic Drug Advisory Committee (ODAC) appointed by the...."
|
|
 |
Gloucester raises $29 million August 25 2009
"Gloucester Pharmaceuticals Inc. (Cambridge, Mass.) raised $29 million in a series D round led by new investor Novo A/S. ...."
|
|
 |
HeartWare International Surpasses 50 Implants In The US August 21 2009
"HeartWare International, Inc. (NASDAQ: HTWR) (ASX: HIN) today announced that HeartWare has surpassed 50 implants in the...."
|
|
 |
HeartWare International, Inc. Closes US$60 Million Financing August 17 2009
"HeartWare International, Inc. (NASDAQ: HTWR) (ASX: HIN) announced today the completion of its offering of approximately...."
|
|
 |
Drug giants pump $40m into Aileron June 9 2009
"Four global pharmaceutical companies have joined in a consortium to provide $40 million in financing to Aileron Therapeutics...."
|
|
 |
Aileron Therapeutics Closes $40M Financing To Advance Stapled Peptide Platform June 8 2009
"Company Developing Novel Class of Stapled Peptide Drugs as Technology Platform for Historically Undruggable Targets...."
|
|
 |
"Emerging Drug Developer" Tokai Pharmaceuticals June 1 2009
"Seth Harrison knows a thing or two about jump-starting a biotech company without breaking the bank...."
|
|
 |
Aileron Advances First Stapled Peptide Drug Candidate
that Targets Newly-Discovered BAX Activation Mechanism October 22, 2008
"Aileron Therapeutics announced today that one
of its proprietary Stapled Peptide compounds, referred to as “BIM-SAHB” in an article published today in Nature..."
|